Drawing for CROSSGLIDE

USPTO serial 88547107

CROSSGLIDE

Reviewed by CopyMark Law Group

Reg. 6267589Status 700Renewal
Filing date
Status date
Registration date
Feb 9, 2021
Examiner
BRACEY, KAREN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CROSSGLIDE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David A. Levine

David A. Levine LEVINE BAGADE HAN LLP2479 E. BAYSHORE ROADSUITE 195PALO ALTO, CA 94303

Goods and services

ClassDescriptionStatusFirst use
010medical devices for use in treating and diagnosing abnormal uterine bleeding, uterine cancer, and other uterine disorders; medical instruments and cannula for insertion into bodily orifices, cavities, and lumena; medical instruments and cannula for insertion into potential spaces within a body; medical devices for use in the field of women's health, namely, medical instruments and catheters for use in gynecological procedures and gynecological surgical procedures; medical kits consisting primarily of medical instruments, catheters, and preparations for diagnosis and treatment of women's health issues; gynecological medical instruments; urological medical instruments for males and females; medical and surgical catheters; catheters and parts and fittings thereof; endoscopic equipment for medical purposes; hysteroscopes; cytoscopes; medical endoscopes; rigid and flexible medical endoscopes; medical devices used to evaluate the uterine cavity and patency of fallopian tubes; medical devices used to evaluate the bladder and urinary function; medical gynecological instruments for examining women's reproductive organs; medical urological instruments for examining the urinary tract function within males and females; nebulizers for medical purposes; medical fluid injectors; catheters for use in biopsies; fallopian tube biopsy instruments; uterine biopsy instruments; biopsy devices, namely, endometrial tissue samplers; biopsy instruments; medical instruments for use in performing biopsies; catheters for use in fallopian tube biopsies; catheters for use in uterine biopsies; medical instruments for uterine cell sampling; medical instrument for fallopian cell sampling; endometrial samplers; cytology brushes; endometrium biopsy suction devices; uterine access devices, namely, dilators and cannulae; incontinence devices, namely, cervical dilators, hysteroscopes, intrauterine devices, and urethral plugs; uterine introducing catheters; balloon catheters; medical balloons; everting medical balloons; everting catheters; everting cervical catheters; medical devices for placing and securing catheters; inflation devices for balloon catheters; catheters for use in uterine access; catheters for use in fallopian tube access; medical balloons for use in cervical transit; medical devices, namely, insemination catheters for delivering reproductive material to the uterus or fallopian tube; embryo transfer catheters and syringes; intra-uterine contraceptive devices; intra-uterine contraceptive device delivery instruments; medical instruments for the transfer of sperm and semen; medical instruments for egg transfer; medical and surgical dilators; vaginal dilators; cervical dilators, bodily lumen or vessel dilators; dilators for potential spaces within a male or female body; uterine dilatorsACTIVEOct 20, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 9, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 8, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Aug 8, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 8, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 8, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 30, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 30, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 30, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 9, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 8, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jan 7, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jan 6, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 6, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 16, 2020IUAFUSE AMENDMENT FILED—
Dec 16, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 16, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 21, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 21, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 1, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 19, 2020ALIEASSIGNED TO LIE—
Mar 13, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 12, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 11, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 11, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 22, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 22, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 22, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 22, 2019DOCKASSIGNED TO EXAMINER—
Aug 9, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 1, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance